Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Observational Study on Evaluation of Glycaemic Control in Patients Using Levemir (Insulin Detemir) as Initiation Insulin Therapy by Levemir (Insulin Detemir) Administered 1 (Once) Daily as the Treatment of Type 2 Diabetes Mellitus.

Trial Profile

Observational Study on Evaluation of Glycaemic Control in Patients Using Levemir (Insulin Detemir) as Initiation Insulin Therapy by Levemir (Insulin Detemir) Administered 1 (Once) Daily as the Treatment of Type 2 Diabetes Mellitus.

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Nov 2016

At a glance

  • Drugs Insulin detemir (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms START
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 19 Apr 2011 Actual patient numbers reported as 2188 by the Clinicaltrials.gov record
    • 19 Apr 2011 Status changed from active, no longer recruiting to completed, as reported by the ClinicalTrials.gov record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top